Assure Holdings Performs First Neuromonitoring Case in South Carolina

DENVER, Colo., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it has performed its first neuromonitoring case in the state of South Carolina.

"Assure is continuing to generate strong organic growth and will remain proactive in expanding within states we currently serve and extending to geographies outside of our current footprint that present compelling opportunities," said John A. Farlinger, Assure's executive chairman and CEO.

Farlinger continued, "The process we use to prioritize our business development opportunities is based on identifying the Company's most promising physician relationships, both those that we developed ourselves as well as referrals from medical device distributors. Additionally, we are now poised to broaden our existing business development funnel by servicing the IONM needs for entire hospitals. The potential financial impact of hospital service contracts is significant as Assure is expected to keep 100% of technical and professional revenue associated with these procedures."

Over the past two years, Assure has extended its operations beyond its home state of Colorado and now provides IONM services in Texas, Louisiana, Utah, Pennsylvania, Michigan and South Carolina. This growth has been driven by the Company's reputation for providing exceptional quality of service and unique clinical expertise. An additional driver to the Company's growth is the increase in demand for neuromonitoring services across numerous medical procedures.

The Company's new Charleston, South Carolina area partner performed approximately 500 procedures in 2019.

About Assure Holdings
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission's Gold Seal of Approval®. For more information, visit the company's website at www.assureneuromonitoring.com.

Forward-Looking Statements
This news release may contain "forward-looking statements" within the meaning of applicable securities laws, including, but not limited to, our expansion plans for our operations in 2020, including our expansion into South Carolina. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the expansion of the Company's operations into South Carolina  and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the Canadian securities regulators and available on the Company's profile on SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-287-3093
[email protected]